AMCO gut microbiome – scientific research on gut microbiome and laboratory analysis of gut dysbiosis.

Who is our AMCO microbiome and gut dysbiosis service designed for?

>>> Pharmaceutical industry, nutraceutics industry, clinical analysis for medical support.

a) Pharmaceutics: collaborations to supply the test to the mass market via the pharmacies.
b) Nutraceutics: collaborations to supply the test to the mass market via the pharmacies.
c) Clinical analysis: private individuals who need accurate and specific analysis of gut dysbiosis.

The AMCO gut dysbiosis and microbiome analysis evaluates the state of imbalance of the gut flora so that preventive action can be taken to rebalance it.

 

History and description of the technology:

We now know that the state of health and wellbeing of an individual is closely related to gut health. In fact, when the gut flora is altered due to various factors (e.g. stress, bad eating habits), an alteration in the individual’s metabolism occurs which leads to various problems (e.g. diabetes, obesity, celiac disease). The AMCO dysbiosis technology effectively monitors the state of gut flora imbalance and identifies the causes. Once this parameter has been obtained, the specialist can provide the most appropriate indications for maintaining gut health and preventing the onset of related diseases. 3 analysis packages are currently available:

a) Platinum Package: consists in the analysis of a stool and urine sample combined with advanced data processing that identifies: the intestinal tract affected by the dysbiosis, the bacterial strains that have caused it and the alteration of the individual’s metabolism. Given the high level of information obtained, it is possible to devise a very accurate prevention strategy.
b) Gold Package: consists in the analysis of a stool and urine sample followed by a database search. This provides information relative to the intestinal tract affected by the dysbiosis and the relative bacterial strains that have caused it. No information is provided on the state of metabolic imbalance of the individual but the level of information is sufficient to intervene in order to rebalance the gut flora.
c) Silver Package: consists in the analysis of a urine sample followed by a database analysis that can identify the presence of a state of dysbiosis. The test is useful for screening purposes and can provide indications for maintaining the gut in a balanced state. If a state of dysbiosis has been detected, the individual can investigate the causes in greater depth by doing the Gold or Platinum analysis, according to the level of information required, and initiate a targeted prevention strategy.

Benefits compared to the analysis technology of our competitors:

The conventional techniques used to identify a state of dysbiosis are based on monitoring of DNA and direct bacterial metabolism. In this way, information is obtained on the presence of bacteria but not their activity at the level of alteration of the metabolism. This limits the range of action at preventive level due to the lack of fundamental information on the biochemical state of the organism. The AMCO technology fills this gap and enables the pharmacist to implement advanced personalized prevention strategies.

RESEARCH AND DEVELOPMENT AND PROTEOMICS ANALYSIS WITH REMOTE MANAGED DATA PROCESSING

Are you looking for Scientific Support in Outsourcing in the field of Target or Untarget Proteomics? Do you need research and development services in the Pharmaceutical, Nutraceutical, Chemical or Clinical Industry? Do you need support in Scientific Research and R&D services using the best Mass Spectrometry laboratory in the world?

Sanist, the only global database, developed by ISB Ionsource Biotech, allows you to take advantage of scientific services on a global scale which until yesterday were the prerogative of local laboratories. This is no longer the case today! Why?

Because ISB Ionsource Biotech makes available to your Research and Development department its many years of Know How enclosed in the only and most powerful database on a global scale which, thanks to Artificial Intelligence and Cloud Technology, allows you to connect your scientific instruments to a patented Electronic Brain which it will exponentially improve the data results of your analytics activities soaring in an incalculable way the effort deriving from the operations of Research and Development and Quality Improvement.


In a nutshell, what can we do for you?

a) Be a classic local laboratory that analyzes and processes samples giving you 300% improved data compared to our competitors in Biotechnology and Bioinformatics.
b) Be yours Remote Scientific Partner, even if you are on the other side of the world, providing you with Patented Technology that will allow you to share the data of your Laboratory Analysis with us, and for us to return to you values improved by 300% compared to what you've gotten so far.






Not yet our customer? Well, it's time to consider a FREE TRIAL of SANIST.

1) Can you try for free? Yes, try SANIST for free without any obligation to use it and at no cost to your facility. 2) Do you have an obligation to use later? Absolutely not, because you will understand by yourself that you will never be able to do without SANIST again. 3) Do you have to move to use SANIST? NO, absolutely not, we will manage everything remotely. 4) Do you have to buy expensive tools to take advantage of SANIST? NO, absolutely not, everything will remain unchanged for you, exponentially improving the data of your Research and Development and Quality activities. 5) Do I have other benefits? YES, you will cut production costs and prehistoric instrumentation which will become obsolete for you.







Tagging: proteomics services, metabolomics journal, foodomics and nutrigenomics, molecule identification, analytical method validation, food analytical methods, food supplements labelling, gut microbiome dysbiosis, blood test biomarkers, oxidative stress markers, untargeted mass spectrometry database, protein quantification assay protocol, pharmaceutical contamination control strategy, mass spectral cloud database, blockchain pharmaceutical, biomarkers identification, breath analysis, personalized medicine companies, precision and personalized medicine, research for pharmaceutical companies